Detalles de la búsqueda
1.
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 7(5): 709-717, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792623
2.
Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat
; 124(2): 419-24, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20300826
3.
Immunochemotherapy as First-line Treatment for Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancers-Reply.
JAMA Oncol
; 7(10): 1580-1581, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410312
4.
The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects.
Med Oncol
; 28(3): 655-60, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354818
5.
Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.
Med Oncol
; 28(4): 1559-64, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20509008
6.
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Ann Hematol
; 83(5): 270-5, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15060745
Resultados
1 -
6
de 6
1
Próxima >
>>